This study aims to develop and validate a prognostic model for neurocritical patients using multimodal brain monitoring data. By combining data from various monitoring techniques such as EEG, TCD, and NIRS, this model will help predict 90-day outcomes (awake, comatose, or deceased) and support personalized treatment decisions. The study is observational and involves no experimental interventions.
Aged 18-80 years, no gender restrictions.
Diagnosed with acute brain injury (ABI), including one of the following: large cerebral infarction, supratentorial large-volume intracerebral hemorrhage, subarachnoid hemorrhage, or severe traumatic brain injury, with imaging evidence (CT or MRI) supporting the diagnosis.
On ICU admission, Glasgow Coma Scale (GCS) eye response = 1 (no eye opening) and motor score ≤ 5 (does not follow commands); or within 48 hours, neurological deterioration with no eye opening and motor score reduced to ≤ 5 (total GCS score ≤ 8).
Able to undergo continuous multimodal monitoring, with an expected ICU stay of ≥72 hours.
Confirmed brain death on admission or imaging showing irreversible brain herniation.
Severe trauma unrelated to brain injury (e.g., multiple fractures, spinal cord injuries, or visceral rupture) that may interfere with brain function monitoring or outcome assessment.
Pre-existing severe neurological disorders such as epilepsy, severe encephalopathy, or chronic intracranial conditions (e.g., brain tumors or hydrocephalus).
Inability to perform multimodal monitoring due to technical issues (e.g., equipment failure or sensor installation problems).
Neurocritical patients aged 18-80 years with acute brain injury admitted to the ICU.
Cohort
Prospective
Not listed
90-day Outcome Prediction
The primary outcome is the prediction of patient status at 90 days post-ICU admission, categorized as awake, comatose, or deceased.
Click on the lead sponsor to view all of their trials.
Xiangya Hospital of Central South University
Lead sponsor
Changsha Fourth Hospital
Collaborator
